Document Detail


Effects of a reduction in circulating insulin by metformin on serum dehydroepiandrosterone sulfate in nondiabetic men.
MedLine Citation:
PMID:  8126125     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Evidence suggests that hyperinsulinemic insulin resistance may reduce serum levels of the adrenal steroid dehydroepiandrosterone (DHEA) sulfate in humans. This study was conducted to assess the influence of physiological concentrations of insulin on serum adrenal steroid levels by lowering circulating insulin in nondiabetic men through the administration of the biguanide metformin. A total of 28 nondiabetic men were studied. The study group consisted of 16 obese and hypertensive men, and the control group of 12 nonobese and normotensive men. The men were studied at baseline and after the oral administration of 500 mg metformin, 3 times daily, for 21 days. Metformin administration resulted in significant reductions in serum insulin levels and concurrent increases in serum DHEA sulfate levels in both groups of men. The mean fasting serum DHEA sulfate concentration rose by 48% in the obese hypertensive men (from 5.9 +/- 0.8 to 8.7 +/- 0.7 mumol/L; P < 0.02) and by 80% in the nonobese normotensive men (from 3.5 +/- 0.5 to 6.3 +/- 0.9 mumol/L; P < 0.05). When the results from both groups were combined, changes in serum DHEA sulfate levels (i.e. day 21 value minus day 0 value) correlated positively with baseline fasting serum insulin levels (r = 0.44; P = 0.02; n = 28). Moreover, changes in fasting serum DHEA sulfate levels correlated inversely with changes in fasting serum insulin levels (r = -0.38; P < 0.05; n = 28). These findings lend further credence to the idea that insulin acts as a physiological regulator of DHEA sulfate metabolism and lowers circulating DHEA sulfate concentrations in men.
Authors:
J E Nestler; N A Beer; D J Jakubowicz; R M Beer
Related Documents :
15162895 - Sulfonylurea treatment of type 2 diabetes mellitus: focus on glimepiride.
2573265 - The safety of amlodipine.
8126125 - Effects of a reduction in circulating insulin by metformin on serum dehydroepiandroster...
9230345 - Metformin does not alter diabetes incidence in the nod mouse.
20662345 - Serum levels of adiponectin and leptin in children born small for gestational age: rela...
22054905 - Diabetes mellitus, hemoglobin a1c, and the incidence of total joint arthroplasty infect...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The Journal of clinical endocrinology and metabolism     Volume:  78     ISSN:  0021-972X     ISO Abbreviation:  J. Clin. Endocrinol. Metab.     Publication Date:  1994 Mar 
Date Detail:
Created Date:  1994-04-12     Completed Date:  1994-04-12     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0375362     Medline TA:  J Clin Endocrinol Metab     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  549-54     Citation Subset:  AIM; IM    
Affiliation:
Department of Internal Medicine, Medical College of Virginia/Virginia Commonwealth University, Richmond 23298.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Dehydroepiandrosterone / analogs & derivatives*,  blood
Dehydroepiandrosterone Sulfate
Humans
Hypertension / blood
Insulin / blood*
Lipids / blood
Male
Metformin / pharmacology*
Obesity / blood
Reference Values
Grant Support
ID/Acronym/Agency:
R01-AG-11227/AG/NIA NIH HHS
Chemical
Reg. No./Substance:
0/Lipids; 11061-68-0/Insulin; 53-43-0/Dehydroepiandrosterone; 651-48-9/Dehydroepiandrosterone Sulfate; 657-24-9/Metformin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Relationship between age, percentage body fat, fitness, and 24-hour growth hormone release in health...
Next Document:  Somatotroph hyperplasia without pituitary adenoma associated with a long standing growth hormone-rel...